None listed
Conditions
Interventions
Dietary Supplement : [Test product]
- Test product: Probiotics
- Main raw material: Lactobacillus rhamnosus
- Appearance and dosage form: White hard capsule/hard capsule containing the contents
- Cont
Sponsors
Ildong Bioscience
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Adult men and women between the ages of 19 and 65 - If you have hard or lumpy stools more than 1 time out of 4, or soft stools less than 1 time out of 4 according to Rome IV standards.
Exclusion criteria
Exclusion criteria: - Those diagnosed with constipation other than constipation-type irritable bowel syndrome - Those with a history of gastrointestinal surgery (excluding appendectomy and cesarean section) - If there are warning symptoms such as rectal bleeding or weight loss - If you currently have a disease that may affect the evaluation of drug efficacy in the digestive system (e.g., organic disease such as colitis, colon cancer, etc.) or have had it within the past 2 years - Probiotics, prebiotics, synbiotics, antibiotics, corticosteroids, antidepressants, antihistamines, non-steroidal anti-inflammatory drugs, and other drugs that affect intestinal motility (laxatives, antidiarrheals, intestinal motility stimulants, and antispasmodics) within the previous 2 weeks. Those who took it - If you have concomitant diseases such as liver cancer or cirrhosis, chronic renal failure, congestive heart failure, or thyroid disease - Pregnant women, lactating women, and women of childbearing potential who plan to become pregnant or breast-feed during the participation period. - Patients with mental illnesses such as depression, schizophrenia, alcoholism, drug addiction, etc. - Those who have hypersensitivity to the test product or ingredients contained in the test product or are allergic to a specific ingredient - Those who participated in another clinical trial within the last 3 months - Subjects who, in the opinion of the researcher, are judged to be unable to comply with the test requirements or are otherwise deemed unsuitable by the doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Data collection and analysis by questionnaires | — |
Secondary
| Measure | Time frame |
|---|---|
| Statistical analysis for metagenome data;Statistical analyses for metabolome data | — |
Countries
Korea, Republic of
Contacts
Public Contacthyeji kwon
Seoul Songdo Hospital
Outcome results
None listed